![Ute Mercker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ute Mercker
Direktor/Vorstandsmitglied bei OMEICOS Therapeutics GmbH
Ursprung des Netzwerks ersten Grades von Ute Mercker
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
IBB Beteiligungsgesellschaft mbH
![]() IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany.
27
| Subsidiary | Investment Managers | 27 |
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany.
12
| Holding Company | Biotechnology | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ute Mercker
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Corporate Officer/Principal | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Institut Pasteur
![]() Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Berlin Capital Fund GmbH
![]() Berlin Capital Fund GmbH Investment ManagersFinance Berlin Capital Fund GmbH invests in innovative companies based in the Berlin-Brandenburg region of Germany. The fund focuses on companies operating in the fields of IT, telecommunications, life sciences, media, trade and commercial services. | Investment Managers | Portfolio Manager-Equities | |
Universität zu Köln | College/University | Doctorate Degree | |
The Rockefeller University | College/University | Corporate Officer/Principal | |
Technical University of Berlin | College/University | Undergraduate Degree | |
Freie Universität Berlin | College/University | Graduate Degree | |
Sanofi-Aventis Deutschland GmbH
![]() Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kyoto University | College/University | Undergraduate Degree | |
Universität Konstanz | College/University | Doctorate Degree | |
Universität Leipzig | College/University | Doctorate Degree | |
Merck Serono SA
![]() Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Humboldt-Universität zu Berlin | College/University | Doctorate Degree | |
Coley Pharmaceutical GmbH
![]() Coley Pharmaceutical GmbH Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Coley Pharmaceutical GmbH is a German company that provides research and development in the field of natural sciences, engineering, agricultural sciences and medicine. The company is based in Berlin, Germany. The company was founded by Heather L. Davis. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
OpenSynergy GmbH
![]() OpenSynergy GmbH Packaged SoftwareTechnology Services OpenSynergy GmbH develops embedded automotive software solutions. It specializes in core products are the modular software development kit COQOS SDK for cockpit controller and connectivity systems and Bluetooth stack Blue SDK. The company was founded by Andr? Hergenhan, Frank-Peter Boehm, Robert Mitschke, Stefaan Sonck Thiebaut and Rolf Morich in 2007 and is headquartered in Berlin, Germany. | Packaged Software | Director/Board Member | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Amakem NV
![]() Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member | |
BIO Deutschland
![]() BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
REDX PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Natural Dental Implants AG
![]() Natural Dental Implants AG Medical SpecialtiesHealth Technology Natural Dental Implants AG provides dental technology products and services. The firm specialized in the development of Replicate, a non-surgical tooth replacement system designed to alternative preserve alveolar bone and adjacent teeth. It offers an alternative solutions to traditional dental implants and three unit dental bridges, with focus on three-dimensional image and impression, natural healing, and temporary and permanent crown features. The company was founded by Ruedger Rubbert and Lea Ellermeier Nesbit in 2009 and is headquartered in Berlin, Germany. | Medical Specialties | Director/Board Member | |
bmp Ventures /Venture Capital/
![]() bmp Ventures /Venture Capital/ Investment ManagersFinance bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg. | Investment Managers | Private Equity Investor | |
K-Invest Beteiligungs GmbH & Co. KG
![]() K-Invest Beteiligungs GmbH & Co. KG Investment ManagersFinance K-Invest Beteiligungs GmbH & Co. KG is a venture capital firm founded in 2010 and having headquartered at Berlin, Germany. | Investment Managers | Private Equity Investor | |
Ypsilon 687 GmbH
![]() Ypsilon 687 GmbH Packaged SoftwareTechnology Services Ypsilon 687 GmbH develops solutions for retail technologies. It provides metrics and analytics for evaluations. Its technology allows retail chains, individual shops, restaurants, boutiques, and supermarkets the cost detection and analysis of customers needs. The comapny was founded by Christian Felix Wallin, Robin Henniges, and Kai Grünenwald on July 26, 2013 and is headquartered in Berlin, Germany. | Packaged Software | Director/Board Member | |
Rigontec GmbH
![]() Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Inflectis Bioscience SAS
![]() Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Biotechnology | Director/Board Member | |
FutuRx Ltd.
![]() FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor | |
ARIX BIOSCIENCE PLC | Investment Managers | Corporate Officer/Principal | |
BioMedx Group, Inc.
![]() BioMedx Group, Inc. Medical SpecialtiesHealth Technology BioMedx Group, Inc. operates as a medical technology company transforming the cosmetic surgery consultation services. The firm engages in product development focus on the modeling and simulation of the human face for aesthetic and facial reconstruction applications. The company was founded by Rudy A. Mazzocchi and is headquartered in Baltimore, MD. | Medical Specialties | Director/Board Member | |
BioMed X GmbH
![]() BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services BioMed X GmbH is an independent research institute that conducts biomedical pre-clinical research projects in the fields of biomedicine, molecular biology, cell biology, and diagnostics. The private company is based in Heidelberg, Germany. The German company sponsors these projects with pharmaceutical partners such as Merck, Boehringer Ingelheim, Johnson & Johnson, AbbVie, and Roche. Talented early-career scientists from all over the world are recruited to work on these projects. The company combines crowdsourcing with local incubation to provide creative solutions to big biomedical research challenges. Each research team has access to state-of-the-art research infrastructure and is guided by experienced mentors from academia and industry. The company was founded in 2013 by Christian Tidona, who has been the CEO since 2013. | Miscellaneous Commercial Services | Director/Board Member | |
Gotham Therapeutics Corp.
![]() Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
x-on Gesellschaft Für Werbung + Marketing mbH
![]() x-on Gesellschaft Für Werbung + Marketing mbH Advertising/Marketing ServicesCommercial Services X-on Gesellschaft Für Werbung + Marketing mbH provides advertising agency services. The private company is based in Hannover, Germany. The German company was founded in 2004. The CEO is Stephan Schulze. | Advertising/Marketing Services | Chief Executive Officer | |
STipe Therapeutics ApS
![]() STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Chairman | |
LP Capital Administration GmbH
![]() LP Capital Administration GmbH Financial ConglomeratesFinance LP Capital Administration GmbH is an investment holding German company. The company is based in Berlin, Germany. The CEOs are Lars Michalak and Thomas Döring. The private company was founded in 2017. | Financial Conglomerates | Chief Executive Officer | |
Twelve Bio
![]() Twelve Bio Miscellaneous Commercial ServicesCommercial Services Part of Ensoma, Inc., Twelve Bio is a Danish company that seeks to expand the breadth of CRISPR-based gene-editing medicines to transform the management of serious diseases. The company is based in Copenhagen, Denmark. Twelve Bio uses its insights into nuclease structure and function to design highly precise and nimble CRISPR-Cas12 candidates for therapeutic application. The company will continuously advance its platform and understanding of Cas enzymes to address the needs of patients worldwide. The company was founded by Stefano Stella, Guillermo Montoya. Twelve Bio was acquired by Ensoma, Inc. on February 09, 2023. | Miscellaneous Commercial Services | Chairman | |
WMT AG
![]() WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Data Information Intelligence GmbH | Founder | ||
High-Tech Gründerfonds Management GmbH
![]() High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor Private Equity Investor | |
Neovii Biotech GmbH
![]() Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Executive Officer |
Statistik
International
Deutschland | 30 |
Vereinigte Staaten | 7 |
Israel | 5 |
Frankreich | 4 |
Vereinigtes Königreich | 3 |
Sektoral
Health Technology | 18 |
Finance | 10 |
Consumer Services | 10 |
Commercial Services | 7 |
Technology Services | 6 |
Operativ
Director/Board Member | 58 |
Private Equity Investor | 29 |
Corporate Officer/Principal | 17 |
Private Equity Analyst | 11 |
Doctorate Degree | 6 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Holger N. Reithinger | 25 |
Bernhard Kirschbaum | 15 |
Taro Inaba | 14 |
Gaston Matthyssens | 12 |
Christian Schetter | 12 |
Martin Pfister | 5 |
Clemens Kabel | 4 |
Lars Michalak | 4 |
Stephan Schulze | 4 |
Karen Uhlmann | 3 |
Marco Zeller | 3 |
Roger Bendisch | 3 |
Peter Seiler | 2 |
Katja Kühnel | 2 |
Markus Lehmann | 1 |
- Börse
- Insiders
- Ute Mercker
- Unternehmensverbindungen